TNFA: TNF Pharmaceuticals Inc. Company Short-Term Debt

TNF Pharmaceuticals (TNFA) is a biotech startup researching molecules to combat metabolic disorders, while the expansion of its project portfolio is accompanied by significant expenditures and a lack of sales. A compact executive team is focused on R&D, and the transparency of financial flows remains moderate. The price action on GURU.Markets shows a value of 0.00, complementing data on a business that relies on developing treatments for inflammation and autoimmune pathologies.

This metric measures the volume of liabilities maturing within one year, where a reduction in debt load minimizes default risk but may signal a contraction of the credit limit. By analyzing the company's short-term debt, an investor assesses the liquidity of TNF Pharmaceuticals (TNFA), whose virtual development model and production outsourcing to US cGMP laboratories allow for the optimization of capital expenditures and the operating cycle.